Your Patients Are Struggling to Find Their Medication — Here's How You Can Help

As a provider managing prostate cancer patients on combined androgen blockade, you may have heard from patients that they're having trouble filling their Bicalutamide (Casodex) prescriptions. While Bicalutamide is not in a formal FDA shortage, localized stock-outs at retail pharmacies are a real issue that can disrupt therapy and cause patient anxiety.

This guide provides actionable strategies for your practice to help patients maintain treatment continuity when they can't find Bicalutamide at their local pharmacy.

Current Availability Overview

Bicalutamide 50 mg tablets are produced by multiple generic manufacturers and remain widely available at the wholesale level. The supply situation as of 2026:

• FDA shortage status: Not in shortage
• Generic manufacturers: 5+ active suppliers (Teva, Viatris/Mylan, Sun Pharma, Accord, others)
• Wholesale availability: Generally in stock at major distributors (McKesson, Cardinal Health, AmerisourceBergen)
• Retail pharmacy availability: Variable — chain pharmacies may not routinely stock it; independent pharmacies generally better
• Price: $20–$24/month (generic with coupon), $0–$15 with most insurance plans

For the full supply and pricing analysis, see our provider shortage briefing.

Why Patients Can't Find It

Understanding the root causes helps you counsel patients effectively:

1. Just-in-Time Pharmacy Inventory

Most chain pharmacies (CVS, Walgreens, Rite Aid) use automated ordering systems that stock medications based on recent fill patterns. If a store hasn't filled many Bicalutamide prescriptions recently, the system may not order it proactively. The medication is available from the wholesaler — the pharmacy just doesn't have it on the shelf.

2. Manufacturer-Specific Ordering

Some pharmacy systems default to ordering from a single preferred generic manufacturer. If that manufacturer has a temporary backorder, the pharmacy may not automatically switch to another supplier's version, even though it's available.

3. Patient Behavior Patterns

Patients who wait until their last pill to request a refill leave no buffer time for ordering. Patients who only try one pharmacy give up too quickly. Education on proactive refill strategies is key.

4. Insurance/Formulary Complications

Occasionally, a patient's insurance may require a specific manufacturer's generic (e.g., an authorized generic), which may be less readily available than other versions. A call from your office to the patient's insurance or PBM can often resolve this.

What Providers Can Do: 5 Practical Steps

Step 1: Verify Stock Before Prescribing

Before e-prescribing Bicalutamide to a specific pharmacy, take 30 seconds to confirm availability. Your clinical staff can use Medfinder to check real-time stock at pharmacies near the patient's location. This prevents the frustrating cycle of prescription → rejection → resubmission.

Step 2: Add Pharmacy Notes

When e-prescribing, include a note: "Any manufacturer generic Bicalutamide acceptable." This gives the pharmacist flexibility to fill from whatever generic supplier they have in stock, avoiding delays caused by manufacturer-specific restrictions.

Step 3: Recommend Independent or Specialty Pharmacies

If a patient reports difficulty at a chain pharmacy, recommend they try:

• Independent community pharmacies: More flexible ordering, often can source within 24 hours
• Oncology specialty pharmacies: Affiliated with cancer centers, routinely stock antiandrogens
• Mail-order pharmacies: Larger inventories, ideal for 90-day maintenance prescriptions

Step 4: Write 90-Day Prescriptions

For stable patients on maintenance therapy, consider writing 90-day prescriptions with refills. This:

• Reduces refill frequency (fewer chances for stock-out encounters)
• Qualifies for mail-order pharmacy pricing (often lower copay)
• Gives the pharmacy advance notice to order adequate supply
• Reduces patient burden and no-show risk for refill appointments

Step 5: Establish a Refill Protocol

Educate patients to request refills 5–7 days before running out. Your office can support this by:

• Setting refill reminders in the EHR
• Including refill timing in discharge/visit instructions
• Having nursing staff do a brief medication access check during follow-up calls

When to Consider Alternatives

If a patient truly cannot access Bicalutamide despite the above strategies, therapeutic alternatives include:

• Flutamide: 250 mg TID. Same class (first-generation NSAA). Higher GI toxicity (diarrhea ~12% vs. ~2% for Bicalutamide), higher hepatotoxicity risk. Generic available at comparable cost.
• Nilutamide: 300 mg daily × 30 days, then 150 mg daily. Visual adaptation delay (13–57%), interstitial pneumonitis risk (~2%). Less commonly stocked than Bicalutamide.

Second-generation antiandrogens (Enzalutamide, Apalutamide, Darolutamide) should only be considered if the clinical indication supports escalation — they are not appropriate as simple supply-driven substitutes in most clinical scenarios. For patient-facing information on alternatives, see our article on alternatives to Casodex.

Workflow Tips for Your Practice

Integrating medication access support into your standard workflow can save time and reduce patient calls:

At the Point of Prescribing

• Confirm pharmacy stock using Medfinder
• Prefer pharmacies that the patient has successfully filled at before
• Include generic manufacturer flexibility notes on the Rx

During Follow-Up Visits

• Ask: "Have you had any trouble filling your Bicalutamide?"
• Review remaining pill count and refill timeline
• Update pharmacy preference if the patient has switched

When Patients Call About Access Issues

• Direct to Medfinder for self-service pharmacy search
• Offer to transfer the prescription to a pharmacy with confirmed stock
• Escalate to your specialty pharmacy network if retail options are exhausted

Patient Assistance Resources to Share

• AZ&Me Program: Free medication for qualifying uninsured/underinsured patients (azandmeapp.com)
• GoodRx / SingleCare: Reduces generic price to $20–$24/month
• NeedyMeds / RxAssist: Comprehensive patient assistance program directories

See also: How to help patients save money on Casodex.

Final Thoughts

Bicalutamide availability issues in 2026 are primarily a last-mile pharmacy stocking problem, not a manufacturing supply crisis. With a few proactive adjustments to your prescribing workflow — stock verification, manufacturer-agnostic prescribing, recommending independent pharmacies, and writing 90-day scripts — you can significantly reduce the likelihood of your patients experiencing treatment gaps.

Tools like Medfinder for Providers make it easy to integrate real-time stock checks into your clinical practice. Your patients are already stressed about their cancer diagnosis — helping them find their medication shouldn't add to that burden.

For the patient perspective, share our guides on finding Casodex in stock and saving money on Casodex.